Immunopathology of Chagas Disease

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue SUPPL. 1, 1999, Pages 71-80

  Andrade, Zilton A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Immunopathology; Myocarditis; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMAL; CELLULAR IMMUNITY; CHAGAS DISEASE; CHRONIC DISEASE; DOG; ELECTRON MICROSCOPY; IMMUNOLOGY; PATHOLOGY; REVIEW;

ACUTE DISEASE; ANIMALS; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; DOGS; IMMUNITY, CELLULAR; MICROSCOPY, ELECTRON;

EID: 0346098191     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000700007     Document Type: Article

References (51)

1. Abrahamsohn IA, Coffman RL 1996. Trypanosoma cruzi: Il-10, TNF, INF-γ, and Il-12 regulate innate and acquired immunity to infection. Exp Parasitol 84: 231-244.
2. Andrade ZA 1984 The canine model of Chagas disease. Mem Inst Oswaldo Cruz 79: 77-83.
3. Andrade ZA, Andrade SG, Correa, R, Sadigursky M, Ferrans VJ 1994. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy. Am J Pathol 144: 1403-1411.
4. Andrade ZA, Andrade SG, Sadigursky M 1987. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol 127: 467-473.
5. Andrade ZA, Andrade SG, Sadigursky M, Wenthold Jr RJ, Hilbert SL, Ferrans VJ 1997. The indeterminate phase of Chagas disease: ultrastructural characterization of cardiac changes in the canine model. Am J Trop Med Hyg 57: 328-336.
6. Anselmi A, Pifano F, Suarez JA, Gurdiel O 1966. Myocardiopathy in Chagas disease. I. Comparative study of pathologic findings in chronic human and experimental Chagas myocarditis. Am Heart J 72: 469-481.
7. Barbosa Jr AA, Andrade ZA 1984. Identificação do Trypanososoma cruzi nos tecidos extracardíacos de portadores de miocardite crônica chagásica. Rev Soc Bras Med Trop 17: 123-126.
8. Cabral HRA 1988. Mastocitos en contacto com fibras musculares cardíacas en miocardio de pacientes com cardiopatia de Chagas severa. Prensa Med Argent 75: 490-496.
9. Cardillo F, Voltarelli JC, Reed SG, Silva JS 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 64: 128-134.
10. Colley DG, Lewis FA, Todd CW 1979. Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol 46: 192-200.
11. Cotran RS, Pober JS, Giambrone Jr MA, Springer TA, Wiebke EA, Gaspari AA, Rosenberg SA, Lotze MT 1987. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leaky syndrome. J Immunol 139: 1883-1888
12. Cunha-Neto E, Duranti M, Gruber A, Zingales B, Messias I, Stolf N, Bellotti G, Patarroyo ME, Pilleggi F, Kalil J 1995. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactivc to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 92: 3541-3545.
13. DosReis GA, Fonseca MEF, Lopes MF 1995. Programmed T-cell death in experimental Chagas disease. Parasitol Today 11: 390-394.
14. Gazzinelli RT, Morato MJ, Nunes RM, Cançado JR, Brener Z, Gazzinelli G 1988. Idiotype stimulation of T lymphocytes from Trypanosoma cruzi-infected patients. J Immunol 140: 3167-3172.
15. Higuchi ML, Brito T, Reis M, Barbosa A, Bellotti G, Pereira Barretto AC, Pileggi F 1993. Correlation between T. cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis. Light microscopy and immunohistochemical findings. Cardiovasc Pathol 2: 101-106.
16. Higuchi M, Reis M, Gutierrez P, Aiello V 1995. Myocardial T. cruzi antigens induces increases of CD8+ but not of CD4+ T cell numbers in human chronic Chagas cardiopathy. Circulation 92 (Suppl. 1): 1-470.
17. Hunter CA, Slifer T, Araujo F 1996. Interleukin-12 mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun 64: 2381-2386.
18. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
19. Kierszembaum F 1986. Autoimmunity in Chagas disease. J Parasitol 72: 201-211.
20. Kumar S, Tarleton RL 1998. The relative contribution of antibody production and CD8+T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20: 207-216.
21. Laranja FS, Andrade ZA 1980. Forma crônica cardíaca da doença de Chagas no cão. Arq Bras Cardiol 35: 377-380.
22. Liew FY, Russel SM 1983. Inhibition of pathogenic effect of effector T cells by specific suppressor T cells during influenza virus infection in mice. Nature 304: 541-543.
23. Lopes ER, Chapadeiro E, Almeida HO, Rocha A 1975. Contribuição ao estudo da anatomia patológica dos corações de chagásicos falecidos subitamente. Rev Soc Bras Med Trop 9: 269-282.
24. Lopes ER, Chapadeiro E, Andrade ZA 1981. Anatomia patológica do coração em chagásicos assintomáticos falecidos de modo violento. Mem Inst Oswaldo Cruz 76: 189-197.
25. Lopes ER, Tafuri WL, Bogliolo L, Almeida HO Chapadeiro E 1977. Miocardite chagásica aguda humana (ganglionite subpicárdica; agressão a fibra cardiaca por linfócitos; relação entre amastigotas e a fibra muscular). Rev Inst Med Trop São Paulo 19: 301-309.
26. Lopes MF, Veiga VF, Santos AR, Fonseca ME, DosReis GA 1995. Activation-Induced CD4+ T cell death by apoptosis in experimental Chagas disease. J Immunol 154: 744-752.
27. Mady C, Pereira-Barretto AC, Ianni BM, Lopes EA, Pileggi F 1984. Right ventricular endomyocardial biopsy in undetermined form of Chagas disease. Angiology 35: 755-759.
28. Molina HA, Kierszenbaum F 1989. Eosinophil activation in acute and chronic chagasic myocardial lesions and deposition of toxic eosinophil granule proteins on heart myofibers. J Parasitol 75: 129-133.
29. Morgan J, Dias JC, Gontijo ED, Oliveira LB, Oliveira RC, Colley DG, Powell MR 1996. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas disease. Am J Trop Med Hyg 55: 355-359.
30. Ouaissi A, Cornette J, Velge P, Capron A 1988. Identification of anti-acetylcholinesterase and anti-idiotype antibodies in human and experimental Chagas disease: pathological implications. Eur J Immunol 18: 1889-1894.
31. Palacios-Pru E, Carrasco H, Scorza C, Espinoza R 1989. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am J Trop Med Hyg 41: 29-40.
32. Reis DA, Jones EM, Tostes Jr S, Lopes ER, Gazzinelli G, Colley DG, McCurley TL 1993. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-α+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637-644.
33. Ribeiro dos Santos R, Hudson L 1980. Trypanosoma cruzi: binding of parasite antigen to mammalian cells. Parasite Immunol 2: 1-10.
34. Ribeiro dos Santos RR, Rossi M, Laus JL, Silva JS, Savino W, Mengel J 1992. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn heartys grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175: 29-39.
35. Rocha A, Meneses ACO, Silva AM, Ferreira MS, Nishioka AS, Burgarelli MKN, Almeida E, Turcato Jr G, Metze K, Lopes ER 1994. Pathology of patients with Chagas disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261-268.
36. Rossi MA 1990. Myocardial damage in Trypanosoma cruzi myocarditis: a role for macrophages. Can J Cardiol 6: 293-298.
37. Rossi MA, Gonçalves S, Ribeiro dos Santos R 1984. Experimental Trypanosoma cruzi myocardiopathy in Balb/c mice: the potential role of intravascular platelet aggregation in its genesis. Am J Pathol 114: 209-216.
38. Sadigursky M, Acosta AM, Santos Buch CA 1982. Muscle sarcoplasmic reticulum antigen shared by a Trypanosoma cruzi clone. Am J Trop Med Hyg 31: 934-941.
39. Schwartz A, Askenase PW, Gershon RK 1978. Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol 121: 1573-1577.
40. Silva JC, Pirmez C, Morgado MG, Galvão B 1985. Immunopathological aspects of experimental Trypanosoma cruzi infection: correlation of immune complexes and other serological features with muscle lesions during the infection. Parasite Immunol 7: 457-466.
41. Silva JS, Vespa GNR, Cardoso MAG, Aliberti JCS, Cunha FO 1995. Tumor necrosis factor alpha mediate resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63: 4862-4867.
42. Smudio M, James SM, Cabral M, Martinez J, Arias AR, James MA 1998. Cytokine responses in Trypanosoma cruzi -infected children in Paraguay. Am J Trop Med Hyg 58: 119-121.
43. Tafuri WL, Lopes ER, Chapadeiro E, Miziara HL, Santos BG, Raso P 1993. Miocardite chagásica humana: provável agressão à célula cardíaca pelo granulócito eosinófilo. Rev Soc Bras Med Trop 16: 122-124.
44. Tanowitz HB, Burns ER, Shina AK, Khan NN, Morris AS, Factor SM, Hatcher VB, Bilezikian JP, Baum SG, Wittner M 1990. Enhanced platelet adherence and aggregation in Chagas disease: a potential pathogenic mechanism to cardiomyopathy. Am J Trop Med Hyg 43: 274-281.
45. Tarleton RL 1993. Pathology of American trypanosomiasis, p. 64-85. In KS Warren, Immunology and Molecular Biology of Parasitic Diseases, 3rd Edition, Blackwell Scientific Publications, Boston.
46. Tarleton RL 1998. Trypanosoma cruzi-induced suppression of Il-2 production. II Evidence for a role for suppressor cells. J Immunol 140: 2769-2773.
47. Tarleton RL, Zhang L, Downs MO 1997. Rejection of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci USA 199: 3932-3937.
48. Tostes Jr S, Lopes ER, Pereira FEL, Chapadeiro E 1994. Miocardite chagásica crônica humana: estudo quantitativo dos linfócitos CD4+ e dos CD8+ no exsudato inflamatório. Rev Soc Bras Med Trop 27: 127-134.
49. Turk JL, Parker D, Poulter LW, 1972. Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology 23: 493-501.
50. Yi ES, Ulich TR 1992. Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in post capillary venules. Am J Pathol 140: 656-663.
51. Zhang J, Yu ZX, Hilbert ST, Yamaguchi M, Chadwick DP, Herman EH, Ferrans VJ 1993. Carditoxicity of human recombinant interleukin-2 in rats: a morphological study. Circulation 87: 13-40.